Medigen Vaccine Biologics Corporation (TPEX:6547)
Taiwan
· Delayed Price · Currency is TWD 42.90
+0.40 (0.94%)
Jun 27, 2025, 2:31 PM CST
Medigen Vaccine Biologics Market Cap
Medigen Vaccine Biologics has a market cap or net worth of 15.02 billion as of June 27, 2025. Its market cap has decreased by -11.40% in one year.
Market Cap
15.02B
Enterprise Value
13.50B
Revenue
662.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
42.90
Market Cap Chart
Since August 6, 2015, Medigen Vaccine Biologics's market cap has increased from 2.83B to 15.02B, an increase of 429.94%. That is a compound annual growth rate of 18.35%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 207.06B |
| PharmaEssentia | 182.30B |
| Bora Pharmaceuticals Co., LTD. | 84.51B |
| Lotus Pharmaceutical | 57.58B |
| Oneness Biotech | 30.80B |
| Polaris Group | 30.51B |
| Center Laboratories | 27.10B |
| Lumosa Therapeutics | 25.58B |